Published in Transl Oncol on December 01, 2009
The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review. Drug Des Devel Ther (2015) 0.77
DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study. Epigenetics (2016) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A (1996) 29.54
Cancer cell cycles. Science (1996) 21.29
Estimating the world cancer burden: Globocan 2000. Int J Cancer (2001) 16.92
The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell (1996) 15.19
The RB and p53 pathways in cancer. Cancer Cell (2002) 8.02
DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet (2000) 6.57
The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta (1998) 4.45
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res (2004) 3.23
p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol (2006) 2.39
p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res (2001) 2.34
Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Cancer Res (2000) 2.18
Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res (2003) 2.03
Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene (2005) 1.90
CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer. Clin Cancer Res (2000) 1.73
DNA methylation in breast cancer. Endocr Relat Cancer (2001) 1.68
The Indian scene. J Clin Oncol (2001) 1.62
DNA methylation and breast cancer. Biochem Pharmacol (2004) 1.57
DNA hypermethylation in breast cancer and its association with clinicopathological features. Cancer Lett (2005) 1.48
Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. Cancer Res (1994) 1.29
Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters. Int J Cancer (1998) 1.27
Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors. Breast Cancer Res (2008) 1.20
DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat (2008) 1.10
Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol (2004) 1.10
Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. J Pathol (2003) 1.05
Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. J Mammary Gland Biol Neoplasia (2004) 1.05
DNA methylation profiles of female steroid hormone-driven human malignancies. Curr Top Microbiol Immunol (2006) 1.05
Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. Cancer Res (1999) 0.99
Pattern of expression of genes linked to epigenetic silencing in human breast cancer. Hum Pathol (2006) 0.97
Methylation of the p16(Ink4a) tumor suppressor gene 5'-CpG island in breast cancer. Cancer Lett (2001) 0.97
The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma. Cancer (2000) 0.94
Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Cancer Res (2001) 0.94
Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma. Clin Cancer Res (2001) 0.87
Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer. J Cancer Res Clin Oncol (2009) 0.84
Estrogen receptor alpha-negative and progesterone receptor-positive breast cancer: lab error or real entity? Pathol Oncol Res (2006) 0.78
Spectral-domain Cirrus high-definition optical coherence tomography is better than time-domain Stratus optical coherence tomography for evaluation of macular pathologic features in uveitis. Am J Ophthalmol (2008) 2.07
Oxidants, antioxidants and carcinogenesis. Indian J Exp Biol (2002) 2.06
Spectral domain optical coherence tomography predates fluorescein angiography in diagnosing central serous chorioretinopathy. Indian J Ophthalmol (2010) 1.50
Low microsatellite instability is associated with poor prognosis in stage C colon cancer. J Clin Oncol (2005) 1.41
An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. Cell Rep (2013) 1.35
Suppression of receptor interacting protein 140 repressive activity by protein arginine methylation. EMBO J (2006) 1.34
Mycobacterium tuberculosis modulates macrophage lipid-sensing nuclear receptors PPARγ and TR4 for survival. J Immunol (2012) 1.30
Spectral-domain cirrus optical coherence tomography of choroidal striations seen in the acute stage of Vogt-Koyanagi-Harada disease. Am J Ophthalmol (2008) 1.26
Associations of MTHFR DNMT3b 4977 bp deletion in mtDNA and GSTM1 deletion, and aberrant CpG island hypermethylation of GSTM1 in non-obstructive infertility in Indian men. Mol Hum Reprod (2007) 1.21
Post-translational modifications of nuclear co-repressor RIP140: a therapeutic target for metabolic diseases. Curr Med Chem (2008) 1.19
Microfilariae of Wucheria bancrofti in bone marrow. Indian J Hematol Blood Transfus (2009) 1.17
A negative regulatory pathway of GLUT4 trafficking in adipocyte: new function of RIP140 in the cytoplasm via AS160. Cell Metab (2009) 1.16
CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin. Mol Cancer (2004) 1.14
Modulation of lysine acetylation-stimulated repressive activity by Erk2-mediated phosphorylation of RIP140 in adipocyte differentiation. Cell Signal (2008) 1.13
An update in the management of malignant pleural effusion. Indian J Palliat Care (2011) 1.12
Role of surgery in breast metastasis from carcinoma of the cervix. Indian J Palliat Care (2011) 1.06
SUMOylation of Tr2 orphan receptor involves Pml and fine-tunes Oct4 expression in stem cells. Nat Struct Mol Biol (2006) 1.02
Hepatitis B virus genotypes in chronic liver disease patients from New Delhi, India. World J Gastroenterol (2006) 1.01
Regulation of retinal dehydrogenases and retinoic acid synthesis by cholesterol metabolites. EMBO J (2006) 1.00
Association of the 16-kDa subunit c of vacuolar proton pump with the ileal Na+-dependent bile acid transporter: protein-protein interaction and intracellular trafficking. J Biol Chem (2004) 0.97
Modulation of testicular receptor 4 activity by mitogen-activated protein kinase-mediated phosphorylation. Mol Cell Proteomics (2006) 0.97
Redox biology of tuberculosis pathogenesis. Adv Microb Physiol (2012) 0.96
Multiple mechanisms of ontogenic regulation of nuclear receptors during rat liver development. Am J Physiol Gastrointest Liver Physiol (2004) 0.96
Hepatitis B virus gene mutations in liver diseases: a report from New Delhi. PLoS One (2012) 0.96
Association of overweight and obesity with breast cancer in India. Indian J Community Med (2011) 0.96
Copy number alterations of the H2AFX gene in sporadic breast cancer patients. Cancer Genet Cytogenet (2008) 0.95
The mechanism of redox sensing in Mycobacterium tuberculosis. Free Radic Biol Med (2012) 0.95
Identification of functionally relevant residues of the rat ileal apical sodium-dependent bile acid cotransporter. J Biol Chem (2006) 0.95
Activation of testicular orphan receptor 4 by fatty acids. Biochim Biophys Acta (2009) 0.94
GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Exp Ther Med (2012) 0.92
Concomitant presence of mutations in mitochondrial genome and p53 in cancer development - a study in north Indian sporadic breast and esophageal cancer patients. Int J Cancer (2008) 0.92
Assessment of risk factors in laryngeal cancer in India: a case-control study. Asian Pac J Cancer Prev (2005) 0.91
Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem (2003) 0.91
Associations of Y-chromosome subdeletion gr/gr with the prevalence of Y-chromosome haplogroups in infertile patients. Eur J Hum Genet (2010) 0.91
Hepatitis B virus genotypes in acute and fulminant hepatitis patients from north India using two different molecular genotyping approaches. Hepatol Res (2006) 0.90
The contribution of genetic and epigenetic changes in granulosa cell tumors of ovarian origin. Clin Cancer Res (2004) 0.90
Idiopathic lymphocytoma cutis: a diagnostic dilemma. BMJ Case Rep (2011) 0.90
Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism. Breast Cancer Res (2007) 0.89
Giant extraosseous Ewing sarcoma of the lung in a young adolescent female--a case report. Acta Orthop Belg (2011) 0.89
Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis. J Gastroenterol Hepatol (2011) 0.89
Human IL10 gene repression by Rev-erbα ameliorates Mycobacterium tuberculosis clearance. J Biol Chem (2013) 0.88
Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytes. PLoS One (2012) 0.88
Development of cardiac hypertrophy by sunitinib in vivo and in vitro rat cardiomyocytes is influenced by the aryl hydrocarbon receptor signaling pathway. Arch Toxicol (2013) 0.87
Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population. Biomarkers (2008) 0.87
Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization. J Cancer Res Clin Oncol (2012) 0.87
Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India. Tumour Biol (2014) 0.87
Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein. BMC Cancer (2014) 0.87
PLIO: an ontology for formal description of protein-ligand interactions. Bioinformatics (2011) 0.86
Influence of ellagic acid on prostate cancer cell proliferation: a caspase-dependent pathway. Asian Pac J Trop Med (2011) 0.86
Constitutive activation of nuclear factor -kB: preferntial homodimerization of p50 subunits in cervical carcinoma. Front Biosci (2005) 0.86
A SRY-HMG box frame shift mutation inherited from a mosaic father with a mild form of testicular dysgenesis syndrome in Turner syndrome patient. BMC Med Genet (2010) 0.84
Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population. Breast Cancer Res Treat (2008) 0.84
Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor. Breast Cancer Res Treat (2010) 0.84
Novel missense mutation in FHIT gene: interpreting the effect in HPV-mediated cervical cancer in Indian women. Mol Cell Biochem (2010) 0.83
Sonographic assessment of cervical lymphadenopathy: role of high-resolution and color Doppler imaging. Head Neck (2011) 0.83
Mitogen-activated protein kinases pathways mediate the sunitinib-induced hypertrophy in rat cardiomyocyte H9c2 cells. Cardiovasc Toxicol (2015) 0.83
Adenomatoid tumour of testis. BMJ Case Rep (2011) 0.83
Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy. J Drug Target (2008) 0.83
Midbrain cues dictate differentiation of human dental pulp stem cells towards functional dopaminergic neurons. J Cell Physiol (2014) 0.82
2-(Hetero(aryl)methylene)hydrazine-1-carbothioamides as potent urease inhibitors. Chem Biol Drug Des (2014) 0.82
Intraoperative cytology--role in bone lesions. Diagn Cytopathol (2010) 0.82
5'-CpG island promoter hypermethylation of the CAV-1 gene in breast cancer patients of Kashmir. Asian Pac J Cancer Prev (2012) 0.82
Hypermethylation analysis of mismatch repair genes (hmlh1 and hmsh2) in locally advanced breast cancers in Indian women. Hum Pathol (2008) 0.81
Association of cytokines in hepatitis E with pregnancy outcome. Cytokine (2014) 0.81
Dose-dependent effect of histamine on liver function markers in immunized rabbits. Exp Toxicol Pathol (2011) 0.81
Hydatid cyst in tail of pancreas. BMJ Case Rep (2011) 0.81
Immunohistochemical expression and mutation study of Prohibitin gene in Indian female breast cancer cases. Med Oncol (2013) 0.81
Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells. Nutr Cancer (2013) 0.81
Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors. Eur J Med Chem (2011) 0.81
Modulation of in vivo immunoglobulin production by endogenous histamine and H1R and H2R agonists and antagonists. Pharmacol Rep (2010) 0.81
Three new novel point mutations localized within and downstream of high-mobility group-box region in SRY gene in three Indian females with Turner syndrome. J Clin Endocrinol Metab (2005) 0.80
Immunological, biochemical and histopathological evaluation of histamine receptors (H1R, H2R, H3R and H4R)-antagonist in rabbit experimental model: a short term study. Exp Toxicol Pathol (2010) 0.80
Extensively drug resistance (XDR) tb is not always fatal. Indian J Tuberc (2009) 0.80
Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy. J Gastroenterol Hepatol (2006) 0.80
In silico drug discovery approaches on grid computing infrastructures. Curr Clin Pharmacol (2010) 0.80
Naringin attenuates the development of carrageenan-induced acute lung inflammation through inhibition of NF-κb, STAT3 and pro-inflammatory mediators and enhancement of IκBα and anti-inflammatory cytokines. Inflammation (2015) 0.80
Effect of fly ash deposition on photosynthesis, growth and yield of rice. Bull Environ Contam Toxicol (2014) 0.80
Microsatellite instability in gallbladder carcinoma. Virchows Arch (2015) 0.80
Stem bromelain-induced macrophage apoptosis and activation curtail Mycobacterium tuberculosis persistence. J Infect Dis (2012) 0.79
Association of pregnancy outcome with cytokine gene polymorphisms in HEV infection during pregnancy. J Med Virol (2014) 0.79
Databases and QSAR for cancer research. Cancer Inform (2007) 0.79
Drug induced pulmonary parenchymal disease. Drug Discov Ther (2014) 0.79
Host-lipidome as a potential target of protozoan parasites. Microbes Infect (2013) 0.79
Mutational and promoter hypermethylation status of FHIT gene in breast cancer patients of Kashmir. Mutat Res (2010) 0.79
The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients. Nucl Med Commun (2016) 0.79
Clearance of cervical human papillomavirus infection by topical application of curcumin and curcumin containing polyherbal cream: a phase II randomized controlled study. Asian Pac J Cancer Prev (2013) 0.79
Aspergillus colonization in patients with bronchogenic carcinoma. Asian Cardiovasc Thorac Ann (2013) 0.79
Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology. Mol Cancer (2010) 0.78
New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India. Arch Virol (2012) 0.78
An efficient thiourea-based colorimetric chemosensor for naked-eye recognition of fluoride and acetate anions: UV-vis and 1HNMR studies. Talanta (2009) 0.78
Expression of DNA damage response genes indicate progressive breast tumors. Cancer Lett (2008) 0.78